title: Cost-utility and expected value of perfect information related to trabectedin in the treatment of metastatic soft-tissue sarcoma: the publicly funded comments explored.
authors.affiliation: ESiOR Oy, Kuopio, Finland. Electronic address: erkki.soini@esior.fi.
authors.forename: E J
authors.initials: EJ
authors.lastname: Soini
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000191:economics* / Q000627:therapeutic use*; D004149:Dioxoles / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D012509:Sarcoma / Q000188:drug therapy*; D044005:Tetrahydroisoquinolines / Q000191:economics* / Q000627:therapeutic use*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D004149:Dioxoles; D044005:Tetrahydroisoquinolines